SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Elicera Therapeutics Secures Chinese Patent Allowance for ELC-401

Swedish clinical-stage immuno-oncology company Elicera Therapeutics said it secured a Chinese patent allowance for ELC-401.

Related stories